II. Opioids and the neuroimmune axis

British Journal of Anaesthesia

Volumn 94, Issue 1, 2005, Pages 3-6

  Williams, J P ^a   Lambert, D G ^a  

^a Pharmacology and Therapeutics Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA4 INTEGRIN; BETA ENDORPHIN; BETA2 INTEGRIN; ENDOMORPHIN 1; ENDOMORPHIN 2; FREUND ADJUVANT; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NOCICEPTIN; OPIATE DERIVATIVE; OPIATE RECEPTOR; PLACEBO; NARCOTIC ANALGESIC AGENT; OPIATE PEPTIDE;

ADRENERGIC SYSTEM; ANALGESIC ACTIVITY; ANTINOCICEPTION; CELL SUSPENSION; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DRUG DOSE REGIMEN; EDITORIAL; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MICROTUBULE; MONOCYTE; NEUROIMMUNOLOGY; NONHUMAN; PAIN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RADIOIMMUNOASSAY; RAT STRAIN; SENSORY NERVE; SPINAL GANGLION; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; DRUG EFFECT; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; PHYSIOLOGY; RAT;

ANALGESICS, OPIOID; ANIMALS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; NEUROIMMUNOMODULATION; OPIOID PEPTIDES; RATS; RECEPTORS, OPIOID, MU;

EID: 16644372225     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aei287     Document Type: Editorial

References (30)

1. Webster NR. Opioids and the immune system. Br J Anaesth 1998; 81: 835-6
2. Cabot PJ. Immune-derived opioids and peripheral antinociception. Clin Exp Pharmacol Physiol 2001; 28: 230-2
3. Brack A, Stein C. The role of the peripheral nervous system in immune cell recruitment. Exp Neurol 2003; 184: 44-9
4. Machelska H, Cabot PJ, Mousa SA, Zhang Q, Stein C. Pain control in inflammation governed by selectins. Nature Med 1998; 4: 1425-8
5. Stein C, Schäfer M, Machelska M. Attacking pain at its source: new perspectives on opioids. Nature Med 2003; 9: 1003-8
6. Rittner HL, Brack A, Machelska H, et al. Opioid peptide-expressing leukocytes. Anesthesiology 2001; 95: 500-8
7. Machelska H, Mousa SA, Brack A, et al. Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1. J Neurosci 2002; 22: 5588-96
8. Shaqura MA, Zöllner C, Mousa SA, Stein C, Schäfer M. Charecterization of m opioid receptor binding and G protein coupling in rat hypothalamus, spinal cord, and primary afferent neurons during inflammatory pain. J Pharmacol Exp Theropeut 2004; 308: 712-7
9. Mousa SA, Machelska H, Schäfer M, Stein C. Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J Neuroimmunol 2002; 126: 5-15
10. Brack A, Rittner HL, Machelska H, et al. Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression. Pain 2004; 108: 67-75
11. Mousa SA, Zhang Q, Sitte N, Ji R, Stein C. β-Endorphin containing memory-cells and m-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 2001; 115: 71-8
12. Zöllner C, Shaqura MA, Bopaiah S, Mousa SA, Stein C, Schäfer M. Painful inflammation-induced increase in m-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol 2003; 64: 202-10
13. Laduron P. Axonal transport of opiate receptors in capsaicin sensitive neurones. Brain Res 1984; 294: 157-60
14. Ninkovic M, Hunt SP, Gleave JRW. Localization of opiate and histamine HI receptors in the primary sensory ganglia and spinal cord. Brain Res 1982; 241: 197-206
15. Machelska H, Brack A, Mousa SA, et al. Selectins and integrins but not platelet-endothelial cell derived adhesion molecule-1 regulate opioid inhibition of inflammatory pain. Br J Pharmacol 2004; 142: 772-80
16. Mousa SA, Shakibaei M, Sitte N, Schäfer M, Stein C. Subcellular pathways of β-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 2004; 145 1331-41
17. Binder W, Mousa SA, Sitte N, Kaiser M, Stein C, Schäfer M. Sympathetic activation triggers opioid release and analgesia within peripheral inflamed tissue. Eur J Neurosci 2004; 20: 92-100
18. Likar R, Mousa SA, Philippitsch G, et al. Increased numbers of opioid expressing inflammatory cells does not alter intraarticular morphine analgesia. Br J Anaesth 2004; 93: 375-80
19. Cox BM. Mechanisms of tolerance. In: Stein C, ed. Opioids in Pain Control. Cambridge: Cambridge University Press, 1999: 109-30
20. Bousselmame R, Michael-Titus A, Costentin J. Desensitization of m-opioid receptors does not modify the analgesia induced by an enkephalinase inhibitor. Eur J Pharmacol 1991; 203: 295-7
21. Kalso E, Smith L, McQuay HJ, Moore RA. No pain, no gain: clinical excellence and scientific rigour-lessons learned from i.a. morphine. Pain 2002; 98: 269-75
22. Eisenach JC, Carpenter R, Curry R. Analgesia from peripherally active k-opioid receptor agonist in patients with chronic pancreatitis. Pain 2003; 101: 89-95
23. Duckett JW, Cangiano T, Cubina M, Howe C, Cohen D. Intravesical morphine analgesia after bladder surgery. J Urol 1997; 157: 1407-9
24. Rorarius M, Souminen P, Baer G, Pajunen P, Tuimala R, Laippala P. Peripherally administered sufentanil inhibits pain perception after postpartum tubal ligation. Pain 1997; 79: 83-8
25. Serhan CN, Fierro IM, Chiang N, Pouliot M. Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin triggered 15-epi-lipoxin A4. J Immunol 2001; 166: 3650-4
26. Fiset ME, Gilbert C, Poubelle PE, Pouliot M. Human neutrophils as a source of nociceptin: a novel link between pain and inflammation. Biochemistry 2003; 42: 10498-505
27. Chen Y, Chang M, Wang ZZ, et al. [Nphe1] nociceptin(1-13)-NH2 antagonizes nociceptin-induced hypotension, bradycardia, and hindquarters vasodilatation in the anesthetized rat. Can J Physiol Pharmacol 2002; 80: 31-5
28. Champion HC, Czapla MA, Kadowitz PJ. Nociceptin, an endogenous ligand for the ORLI receptor, decreases cardiac output and total peripheral resistance in the rat. Peptides 1997; 18: 729-32
29. Champion HC, Pierce RL, Kadowitz PJ. Nociceptin, a novel endogenous ligand for the ORLI receptor, dilates isolated resistance arteries from the rat. Reg Peptides 1998; 78: 69-74
30. Miyata R, Iwabuchi K, Watanabe S, Sato N, Nagaoka I. Short exposure of intestinal epithelial cells to TNF-alpha and histamine induces Mac-1 mediated neutrophil adhesion independent of protein synthesis. J Leucocyte Biol 1999; 66: 437-46